Lilinorm

Hydrocortisone, the active ingredient in Lilinorm, is a corticosteroid presented as an oral formulation for systemic use. It replaces deficient cortisol in adrenal insufficiency and reduces inflammation in a range of conditions for adults and children as prescribed.

GNH USA supplies Lilinorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrocortisone acts on the endocrine and inflammatory pathways to restore glucocorticoid balance and suppress excess inflammation. - Adrenal insufficiency: replaces deficient cortisol and prevents adrenal crisis. - Congenital adrenal hyperplasia: provides glucocorticoid control of excess androgen production. - Inflammatory conditions: reduces inflammation and symptom severity in disorders such as rheumatoid arthritis or severe dermatitis.

Hydrocortisone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hyperglycemia: elevated blood sugar levels. - Fluid retention: swelling of the ankles or face. - Hypertension: increased blood pressure. - Mood changes: irritability or euphoria. - Gastrointestinal upset: nausea or abdominal discomfort. - Weight gain: increased appetite and fat deposition.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: heightened susceptibility to bacterial, viral or fungal infections. - Cushingoid appearance: moon face, central obesity, skin thinning. - Osteoporosis: loss of bone density with prolonged use. - Psychosis or severe mood disorders. - Anaphylaxis: rare but potentially life‑threatening allergic reaction.

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly. - Assess adrenal function: confirm need for glucocorticoid replacement. - Monitor blood glucose: adjust antidiabetic therapy as needed. - Monitor blood pressure: watch for hypertension development. - Use the lowest effective dose: limit duration to reduce adverse effects. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Store at ambient temperature: keep in the original pack, protect from moisture.

Hydrocortisone can alter the activity of several co‑administered medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure. - Anticoagulants (e.g., warfarin): enhanced anticoagulant effect. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of gastrointestinal bleeding. - Live vaccines: reduced vaccine efficacy. - Loop diuretics: may exacerbate hypokalemia.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce hydrocortisone levels. - Antidiabetic agents (e.g., insulin): may require dose adjustment for hyperglycemia. - Antihypertensives: possible reduction in blood‑pressure control. - Anticonvulsants (e.g., phenytoin): may lower glucocorticoid effect. - Antifungal azoles (e.g., fluconazole): may modestly increase exposure.